ANDA 72705, held by Dava Pharms Inc. Prazosin Hydrochloride.
As of Nov 16, 2026, ANDA 72705 (Prazosin Hydrochloride), held by Dava Pharms Inc, was first approved by FDA on Mar 15, 1989, with 8 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Mar 15, 1989 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Prazosin HydrochlorideEQ 1MG BASE ยท capsule;oral | Prazosin Hydrochloride | Discontinued |
| Sep 6, 2001 | Supplement 7Manufacturing | Approved | None posted |
| Sep 6, 2001 | Supplement 8Manufacturing | Approved | None posted |
| Oct 6, 1998 | Supplement 6Manufacturing | Approved | None posted |
| May 11, 1995 | Supplement 3Manufacturing | Approved | None posted |
| Jul 28, 1994 | Supplement 4Manufacturing | Approved | None posted |
| Jul 28, 1994 | Supplement 5Manufacturing | Approved | None posted |
| Apr 20, 1992 | Supplement 1Manufacturing | Approved | None posted |
| Jan 17, 1991 | Supplement 2Labeling | Approved | None posted |
| Mar 15, 1989 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters